Committee Composition

  Audit Compensation and Management Development Nominating and Corporate Governance
Lewis T. "Rusty" Williams, M.D., Ph.D. Chairman of the Board      
Franklin M. Berger, CFA Committee Chair for Audit Committee   Member of Nominating and Corporate Governance Committee
Garry Nicholson Member of Audit Committee    

Mr. Nicholson has served as a member of our board of directors since May 2017. Mr. Nicholson served as President and Chief Executive Officer of XTuit Pharmaceuticals, Inc., from September 2015 to October 2016. From May 2008 to March 2015, Mr. Nicholson served at Pfizer Inc. as President, Pfizer Oncology. Prior to joining Pfizer, Mr. Nicholson worked at Eli Lilly and Company where he held roles of increasing responsibility, most recently as the Global Oncology Platform Leader. Mr. Nicholson currently serves on the board of directors of Tesaro, Inc., a public pharmaceutical company. Mr. Nicholson received a B.S. in Pharmacy from the University of North Carolina at Chapel Hill and an M.B.A. from the University of South Carolina.


Sheila Gujrathi, M.D.   Committee Chair for Compensation and Management Development Committee  
Peder K. Jensen, M.D.   Member of Compensation and Management Development Committee Committee Chair for Nominating and Corporate Governance Committee
Mark D. McDade   Member of Compensation and Management Development Committee  
William R. Ringo Member of Audit Committee   Member of Nominating and Corporate Governance Committee
Chair of the Board = Chair of the Board Committee Chair = Chair Committee Member = Member

FPRX (Common Stock)

Exchange
NASDAQ
Price
21.19
Change (%)
0.00
Volume
N/A

Data as of 4:15 PM ET on Friday, January 12, 2018
Minimum 20 minute delay
Refresh quote
Powered By eSignal, Inc.